IL115973A - Acylated insulin analogs and pharmaceutical compositions containing them - Google Patents

Acylated insulin analogs and pharmaceutical compositions containing them

Info

Publication number
IL115973A
IL115973A IL11597395A IL11597395A IL115973A IL 115973 A IL115973 A IL 115973A IL 11597395 A IL11597395 A IL 11597395A IL 11597395 A IL11597395 A IL 11597395A IL 115973 A IL115973 A IL 115973A
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
compositions containing
insulin analogs
acylated insulin
acylated
Prior art date
Application number
IL11597395A
Other languages
English (en)
Other versions
IL115973A0 (en
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL115973A0 publication Critical patent/IL115973A0/xx
Publication of IL115973A publication Critical patent/IL115973A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL11597395A 1994-11-17 1995-11-14 Acylated insulin analogs and pharmaceutical compositions containing them IL115973A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/342,931 US5693609A (en) 1994-11-17 1994-11-17 Acylated insulin analogs

Publications (2)

Publication Number Publication Date
IL115973A0 IL115973A0 (en) 1996-01-31
IL115973A true IL115973A (en) 2001-08-26

Family

ID=23343907

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11597395A IL115973A (en) 1994-11-17 1995-11-14 Acylated insulin analogs and pharmaceutical compositions containing them

Country Status (25)

Country Link
US (2) US5693609A (fr)
EP (1) EP0712861B1 (fr)
JP (1) JPH10511644A (fr)
KR (1) KR970706842A (fr)
AR (1) AR002700A1 (fr)
AT (1) ATE237635T1 (fr)
AU (1) AU711282B2 (fr)
BR (1) BR9509653A (fr)
CA (1) CA2205060A1 (fr)
CO (1) CO4520284A1 (fr)
CZ (1) CZ145797A3 (fr)
DE (1) DE69530353T2 (fr)
ES (1) ES2194890T3 (fr)
FI (1) FI972031A (fr)
HU (1) HUT77030A (fr)
IL (1) IL115973A (fr)
NO (1) NO972169L (fr)
NZ (1) NZ297257A (fr)
PL (1) PL320644A1 (fr)
RU (1) RU2160118C2 (fr)
TR (1) TR199501420A2 (fr)
TW (1) TW434259B (fr)
WO (1) WO1996015804A1 (fr)
YU (1) YU71395A (fr)
ZA (1) ZA959679B (fr)

Families Citing this family (150)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0537524A1 (fr) 1991-10-17 1993-04-21 Shipley Company Inc. Compositions sensibles aux radiations et procédés
GB9316895D0 (en) 1993-08-13 1993-09-29 Guy S And St Thomas Hospitals Hepatoselective insulin analogues
US6869930B1 (en) * 1993-09-17 2005-03-22 Novo Nordisk A/S Acylated insulin
US5693609A (en) * 1994-11-17 1997-12-02 Eli Lilly And Company Acylated insulin analogs
US6251856B1 (en) 1995-03-17 2001-06-26 Novo Nordisk A/S Insulin derivatives
US20010041786A1 (en) * 1995-06-07 2001-11-15 Mark L. Brader Stabilized acylated insulin formulations
US5631347A (en) * 1995-06-07 1997-05-20 Eli Lilly And Company Reducing gelation of a fatty acid-acylated protein
AU2284697A (en) 1996-04-11 1997-10-29 University Of British Columbia, The Fusogenic liposomes
US5948751A (en) * 1996-06-20 1999-09-07 Novo Nordisk A/S X14-mannitol
US5905140A (en) * 1996-07-11 1999-05-18 Novo Nordisk A/S, Novo Alle Selective acylation method
ES2230607T3 (es) * 1996-07-11 2005-05-01 Novo Nordisk A/S Metodo selectivo de acilacion.
ATE417622T1 (de) 1996-08-08 2009-01-15 Amylin Pharmaceuticals Inc Regulation gastrointestinaler beweglichkeit
UA65549C2 (uk) * 1996-11-05 2004-04-15 Елі Ліллі Енд Компані Спосіб регулювання ожиріння шляхом периферійного введення аналогів та похідних glp-1 (варіанти) та фармацевтична композиція
US6310038B1 (en) 1997-03-20 2001-10-30 Novo Nordisk A/S Pulmonary insulin crystals
HUP0004169A3 (en) * 1997-10-24 2001-06-28 Lilly Co Eli Insoluble insulin compositions and process for production thereof
US6444641B1 (en) 1997-10-24 2002-09-03 Eli Lilly Company Fatty acid-acylated insulin analogs
ZA989744B (en) * 1997-10-31 2000-04-26 Lilly Co Eli Method for administering acylated insulin.
US6933272B1 (en) 1998-09-22 2005-08-23 Erik Helmerhorst Use of non-peptidyl compounds for the treatment of insulin related ailments
US6159931A (en) * 1998-09-29 2000-12-12 The Ohio State University Lipid-modified insulin incorporated liposomes for selectively delivering cytotoxic agents to hepatoma cells
AU4904800A (en) * 1999-05-27 2000-12-18 Robert Z-T. Luo Identification of compounds for modulating dimeric receptors
US6309633B1 (en) 1999-06-19 2001-10-30 Nobex Corporation Amphiphilic drug-oligomer conjugates with hydroyzable lipophile components and methods for making and using the same
US7169889B1 (en) 1999-06-19 2007-01-30 Biocon Limited Insulin prodrugs hydrolyzable in vivo to yield peglylated insulin
PT1666028E (pt) * 1999-10-29 2010-06-15 Novartis Ag Composições de pós anidros com melhor dispersividade
EP1346726A4 (fr) * 2000-12-25 2004-09-15 Shiseido Co Ltd Composition de parfum stimulant le systeme sympathique
US7060675B2 (en) * 2001-02-15 2006-06-13 Nobex Corporation Methods of treating diabetes mellitus
US7905230B2 (en) * 2001-05-09 2011-03-15 Novartis Ag Metered dose inhaler with lockout
US6858580B2 (en) * 2001-06-04 2005-02-22 Nobex Corporation Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6835802B2 (en) * 2001-06-04 2004-12-28 Nobex Corporation Methods of synthesizing substantially monodispersed mixtures of polymers having polyethylene glycol moieties
US7713932B2 (en) 2001-06-04 2010-05-11 Biocon Limited Calcitonin drug-oligomer conjugates, and uses thereof
US6828297B2 (en) 2001-06-04 2004-12-07 Nobex Corporation Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6828305B2 (en) 2001-06-04 2004-12-07 Nobex Corporation Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6713452B2 (en) 2001-06-04 2004-03-30 Nobex Corporation Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US7540284B2 (en) * 2001-06-20 2009-06-02 Novartis Pharma Ag Powder aerosolization apparatus and method
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
US7030082B2 (en) * 2001-09-07 2006-04-18 Nobex Corporation Pharmaceutical compositions of drug-oligomer conjugates and methods of treating disease therewith
US6770625B2 (en) * 2001-09-07 2004-08-03 Nobex Corporation Pharmaceutical compositions of calcitonin drug-oligomer conjugates and methods of treating diseases therewith
US6913903B2 (en) * 2001-09-07 2005-07-05 Nobex Corporation Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
US7166571B2 (en) 2001-09-07 2007-01-23 Biocon Limited Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
US7312192B2 (en) * 2001-09-07 2007-12-25 Biocon Limited Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
ES2569262T3 (es) * 2001-10-18 2016-05-09 Nektar Therapeutics Conjugados poliméricos de antagonistas de opioides
JP4739672B2 (ja) * 2001-12-21 2011-08-03 ネクター セラピューティクス 湿気のバリアを有するカプセルパッケージ
EP1472140A1 (fr) * 2001-12-21 2004-11-03 Nektar Therapeutics Appareil et procede de scellage de cavites
DE60335797D1 (de) * 2002-05-07 2011-03-03 Novo Nordisk As Lösliche formulierungen, die monomeres insulin und acyliertes insulin enthalten
US6941980B2 (en) * 2002-06-27 2005-09-13 Nektar Therapeutics Apparatus and method for filling a receptacle with powder
CA2503247A1 (fr) * 2002-10-23 2004-05-06 Intronn, Inc. Procedes de criblage destines a identifier des molecules de pre-trans-epissage efficaces
US7516741B2 (en) * 2002-12-06 2009-04-14 Novartis Ag Aerosolization apparatus with feedback mechanism
US20040206350A1 (en) * 2002-12-19 2004-10-21 Nektar Therapeutics Aerosolization apparatus with non-circular aerosolization chamber
US20050236296A1 (en) * 2002-12-30 2005-10-27 Nektar Therapeutics (Formerly Inhale Therapeutic Systems, Inc.) Carry case for aerosolization apparatus
CA2508870C (fr) 2002-12-30 2012-10-16 Nektar Therapeutics Atomiseur avec formation d'un premier film
US7669596B2 (en) * 2002-12-31 2010-03-02 Novartis Pharma Ag Aerosolization apparatus with rotating capsule
MXPA05007165A (es) 2002-12-31 2005-09-21 Nektar Therapeutics Al Corp Reactivos polimericos que comprnden una cetona o un grupo funcional relacionado.
HUE026950T2 (en) * 2003-04-09 2016-08-29 Novartis Ag Nozzle with guide wire for puncturing the capsule
US8869794B1 (en) 2003-04-09 2014-10-28 Novartis Pharma Ag Aerosolization apparatus with capsule puncturing member
PL1610850T3 (pl) * 2003-04-09 2012-11-30 Novartis Ag Urządzenie rozpylające z osłoną wlotu powietrza
JP5048332B2 (ja) 2003-05-23 2012-10-17 ネクター セラピューティクス 特定の原子配置を有するポリマー誘導体
ES2328579T3 (es) * 2003-07-25 2009-11-16 Conjuchem Biotechnologies Inc. Derivados de insulina de larga duracion y procedimientos asociados.
AU2004274489B2 (en) 2003-09-17 2011-06-09 Nektar Therapeutics Multi-arm polymer prodrugs
US20050214224A1 (en) * 2003-11-04 2005-09-29 Nektar Therapeutics Lipid formulations for spontaneous drug encapsulation
US20050214250A1 (en) 2003-11-06 2005-09-29 Harris J M Method of preparing carboxylic acid functionalized polymers
WO2005047508A1 (fr) 2003-11-14 2005-05-26 Novo Nordisk A/S Procede de fabrication d'insuline acylee
US7790835B2 (en) * 2003-12-03 2010-09-07 Nektar Therapeutics Method of preparing maleimide functionalized polymers
US20060182692A1 (en) 2003-12-16 2006-08-17 Fishburn C S Chemically modified small molecules
EP2604282B1 (fr) 2003-12-16 2019-06-19 Nektar Therapeutics Procédé pour préparer de l'oligoéthylèneglycol monodisperse.
EP1701714A2 (fr) * 2004-01-07 2006-09-20 Nektar Therapeutics Compositions a liberation prolongee amelioree pour la delivrance de proteines pharmaceutiques
WO2005108463A2 (fr) 2004-05-03 2005-11-17 Nektar Therapeutics Al, Corporation Dérivés de polymères comprenant un point de ramification de type acétal ou cétal
US9085659B2 (en) * 2004-05-03 2015-07-21 Nektar Therapeutics Polymer derivatives comprising an imide branching point
MXPA06015049A (es) 2004-07-08 2007-02-08 Novo Nordisk As Marcadores prolongadores de polipeptidos que comprenden una porcion tetrazol.
EP2626368B1 (fr) 2004-07-19 2016-12-21 Biocon Limited Conjugués insuline-oligomère, formulations et utilisations de ceux-ci
EP1789074A4 (fr) * 2004-08-09 2009-08-12 Alios Biopharma Inc Variants de polypeptides synthetiques hyperglycosyles resistants a la protease, formulations orales et leurs procedes d'utilisation
US7597884B2 (en) 2004-08-09 2009-10-06 Alios Biopharma, Inc. Hyperglycosylated polypeptide variants and methods of use
US7833513B2 (en) 2004-12-03 2010-11-16 Rhode Island Hospital Treatment of Alzheimer's Disease
ES2490243T3 (es) * 2005-02-02 2014-09-03 Novo Nordisk A/S Derivados de insulina
JP5087539B2 (ja) * 2005-05-18 2012-12-05 ネクター セラピューティックス 気管支内治療のためのバルブ、デバイス、および方法
ES2341285T3 (es) 2005-07-19 2010-06-17 Nektar Therapeutics Metodo para preparar maleimidas polimericas.
RS53847B1 (en) 2005-07-29 2015-08-31 Nektar Therapeutics PROCEDURES FOR OBTAINING POLYMER REAGENTS
EP1917363B1 (fr) 2005-08-16 2011-06-22 Novo Nordisk A/S Procede permettant de realiser des polypeptides d'insuline matures
AU2006297394B9 (en) * 2005-09-29 2013-09-19 Novartis Ag Receptacles and kits, such as for dry powder packaging
US20070116649A1 (en) 2005-09-29 2007-05-24 Nektar Therapeutics Antibiotic formulations, unit doses, kits, and methods
DK1969004T3 (da) 2005-12-28 2011-11-28 Novo Nordisk As Insulinsammensætninger og metode til at lave en sammensætning
CN101400363B (zh) * 2006-01-18 2012-08-29 昌达生物科技公司 具有增强的稳定性的药物组合物
WO2007121318A2 (fr) 2006-04-12 2007-10-25 Emisphere Technologies, Inc. Préparations destinées à l'administration d'insuline
CA2649235A1 (fr) * 2006-05-09 2007-11-15 Frantisek Hubalek Derive insulinique
BRPI0715469A2 (pt) 2006-07-11 2013-03-12 Qps Llc composiÇÕes farmacÊuticas para a liberaÇço sustentada de peptÍdeos
EP2049149B1 (fr) * 2006-07-31 2015-04-15 Novo Nordisk A/S Insulines pegylées à extensions
PT2074141T (pt) 2006-09-22 2016-11-10 Novo Nordisk As Análogos de insulina resistentes a proteases
EP2069502B1 (fr) 2006-09-27 2014-02-26 Novo Nordisk A/S Procédé de fabrication de polypeptides d'insuline mature
WO2008051621A2 (fr) * 2006-10-25 2008-05-02 Novartis Ag Appareil de dispersion de poudre, procédé de fabrication et d'utilisation de l'appareil et composant pouvant être utilisé sur l'appareil et d'autres dispositifs
EP2425820B1 (fr) 2007-02-11 2015-04-08 MAP Pharmaceuticals Inc Procédé pour l'administration thérapeutique de DHE pour soulager rapidement la migraine tout en diminuant son profil d'effets secondaires
US20080260820A1 (en) * 2007-04-19 2008-10-23 Gilles Borrelly Oral dosage formulations of protease-resistant polypeptides
US9387176B2 (en) 2007-04-30 2016-07-12 Novo Nordisk A/S Method for drying a protein composition, a dried protein composition and a pharmaceutical composition comprising the dried protein
KR20100017667A (ko) * 2007-06-01 2010-02-16 노보 노르디스크 에이/에스 안정한 비-수성의 약학 조성물
US9034818B2 (en) 2007-06-13 2015-05-19 Novo Nordisk A/S Pharmaceutical formulations comprising an insulin derivative
KR20100053561A (ko) 2007-08-15 2010-05-20 노보 노르디스크 에이/에스 아실 및 알킬렌 글리콜 부분을 갖는 인슐린 유사체
BRPI0818004B8 (pt) 2007-10-16 2021-05-25 Biocon Ltd composição farmacêutica sólida administrável por via oral e o processo da mesma.
JP5350388B2 (ja) * 2007-10-25 2013-11-27 ノバルティス アーゲー 単位用量薬物パッケージの粉体調整
US9260502B2 (en) 2008-03-14 2016-02-16 Novo Nordisk A/S Protease-stabilized insulin analogues
PL2254906T3 (pl) 2008-03-18 2017-04-28 Novo Nordisk A/S Stabilizowane względem proteaz, acylowane analogi insuliny
SI2285439T1 (sl) * 2008-04-04 2014-05-30 Nektar Therapeutics Naprava za aerosolizacijo
TWI451876B (zh) 2008-06-13 2014-09-11 Lilly Co Eli 聚乙二醇化之離脯胰島素化合物
WO2010014258A2 (fr) * 2008-08-01 2010-02-04 Nektar Therapeutics Al, Corporation Conjugués possédant une liaison libérable
EP2331140B1 (fr) 2008-08-11 2018-07-04 Nektar Therapeutics Conjugués d'alcanoate polymère à multiples bras
CN102209541B (zh) 2008-09-08 2016-05-18 小利兰·斯坦福大学托管委员会 醛脱氢酶活性调节剂和其使用方法
JP5766118B2 (ja) * 2008-09-11 2015-08-19 ウェルズ ファーゴ バンク ナショナル アソシエイション ポリマー性アルファ−ヒドロキシアルデヒドおよびケトン反応剤ならびに抱合方法
EP2341942A1 (fr) 2008-09-19 2011-07-13 Nektar Therapeutics Conjugués polymères de peptides thérapeutiques
WO2010062308A1 (fr) 2008-10-28 2010-06-03 The Board Of Trustees Of The Leland Stanford Junior University Modulateurs d’aldéhyde déshydrogénase et procédés d’utilisation de ceux-ci
CA2738615A1 (fr) * 2008-10-30 2010-05-06 Novo Nordisk A/S Traitement du diabete a l'aide d'injections d'insuline avec une frequence inferieure a une injection par jour
NZ594248A (en) 2009-01-28 2015-03-27 Smartcells Inc Conjugate based systems for controlled drug delivery
WO2010088286A1 (fr) 2009-01-28 2010-08-05 Smartcells, Inc. Conjugués synthétiques et leurs utilisations
RU2011135730A (ru) 2009-01-28 2013-03-10 Смартселлз, Инк. Кристаллические инсулин-коньюгаты
US8846103B2 (en) 2009-01-28 2014-09-30 Smartcells, Inc. Exogenously triggered controlled release materials and uses thereof
AU2010212794A1 (en) 2009-02-12 2011-08-11 Proyecto De Biomedicina Cima, S.L. Use of cardiotrophin- 1 for the treatment of metabolic diseases
WO2010107964A1 (fr) 2009-03-18 2010-09-23 Pleiades Cardio-Therapeutics, Inc. Doses unitaires, aérosols, trousses, et méthodes pour traiter des affections cardiaques par administration pulmonaire
US8623345B2 (en) 2009-03-20 2014-01-07 Smartcells Terminally-functionalized conjugates and uses thereof
WO2010107520A1 (fr) 2009-03-20 2010-09-23 Smartcells, Inc. Conjugués d'insulines non déposées solubles et leurs utilisations
AU2010273955B2 (en) 2009-07-17 2015-08-06 Nektar Therapeutics Negatively biased sealed nebulizers systems and methods
EP2504019A2 (fr) 2009-11-25 2012-10-03 ArisGen SA Composition à libération par voie muqueuse contenant un peptide, un agent de couronne et/ou un contre-ion
EA024879B1 (ru) 2010-01-19 2016-10-31 Нектер Терепьютикс Идентификация сухих элементов распылителя
AU2011282977A1 (en) 2010-07-28 2013-02-21 Smartcells, Inc. Drug-ligand conjugates, synthesis thereof, and intermediates thereto
WO2012015692A2 (fr) 2010-07-28 2012-02-02 Smartcells, Inc. Polypeptides d'insuline exprimés de façon recombinante et utilisations de ceux-ci
JP2013541500A (ja) 2010-07-28 2013-11-14 スマートセルズ・インコーポレイテツド 組換えレクチン、結合部位修飾レクチンおよびそれらの用途
BR112013010345A2 (pt) 2010-10-27 2017-07-25 Novo Nordisk As tratamento de diabetes melitus usando as injeções de insulina administradas com intervalos de variação da injeção
WO2012088422A1 (fr) 2010-12-22 2012-06-28 Nektar Therapeutics Conjugués promédicaments polymères à plusieurs bras de composés à base de taxane
WO2012088445A1 (fr) 2010-12-22 2012-06-28 Nektar Therapeutics Conjugués promédicaments polymères à plusieurs bras de composés à base de cabazitaxel
US10457659B2 (en) 2011-04-29 2019-10-29 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for increasing proliferation of adult salivary stem cells
WO2012166555A1 (fr) 2011-05-27 2012-12-06 Nektar Therapeutics Composés à base de médicament et de fraction de liaison liée à un polymère soluble dans l'eau
EP2790761B1 (fr) 2011-12-16 2022-05-11 Novartis AG Appareil passif d'aérosolisation de poudre
MX2014012096A (es) 2012-04-11 2014-11-21 Novo Nordisk As Formulaciones de insulina.
SG11201406492YA (en) 2012-04-16 2014-11-27 Cantab Biopharmaceuticals Patents Ltd Optimised subcutaneous therapeutic agents
US9707276B2 (en) 2012-12-03 2017-07-18 Merck Sharp & Dohme Corp. O-glycosylated carboxy terminal portion (CTP) peptide-based insulin and insulin analogues
JP6410790B2 (ja) 2013-03-14 2018-10-24 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー ミトコンドリアアルデヒドデヒドロゲナーゼ−２調節因子およびその使用方法
US10137172B2 (en) 2013-04-30 2018-11-27 Novo Nordisk A/S Administration regime
EP3052134B1 (fr) 2013-10-04 2021-05-05 Merck Sharp & Dohme Corp. Conjugués d'insuline sensibles au glucose
CA2926701A1 (fr) 2013-10-07 2015-04-16 Novo Nordisk A/S Nouveau derive d'un analogue de l'insuline
AR099569A1 (es) 2014-02-28 2016-08-03 Novo Nordisk As Derivados de insulina y los usos médicos de estos
US9656017B2 (en) 2014-06-20 2017-05-23 Howard E. Greene Infusion delivery devices and methods
WO2017127420A1 (fr) 2016-01-19 2017-07-27 Nektar Therapeutics Réservoir de liquide scellé pour un nébuliseur
CA3012333A1 (fr) 2016-02-01 2017-08-10 Incarda Therapeutics, Inc. Combinaison de la surveillance electronique avec une therapie pharmacologique par inhalation pour gerer des arythmies cardiaques dont la fibrillation auriculaire
EP3554534B1 (fr) 2016-12-16 2021-06-23 Novo Nordisk A/S Compositions pharmaceutiques contenant de l'insuline
KR20200003199A (ko) 2017-05-10 2020-01-08 인카다 테라퓨틱스, 인크. 폐 투여에 의해 심장 병태를 치료하기 위한 단위 용량, 에어로졸, 키트 및 방법
EP3668892A1 (fr) 2017-08-17 2020-06-24 Novo Nordisk A/S Nouveaux analogues d'insuline acylés et leurs utilisations
WO2019125878A1 (fr) 2017-12-18 2019-06-27 Merck Sharp & Dohme Corp. Systèmes à base de conjugués pour l'administration contrôlée d'insuline
US11413352B2 (en) 2017-12-18 2022-08-16 Merck, Sharp & Dohme LLC Conjugate based systems for controlled insulin delivery
US10744087B2 (en) 2018-03-22 2020-08-18 Incarda Therapeutics, Inc. Method to slow ventricular rate
US10335464B1 (en) 2018-06-26 2019-07-02 Novo Nordisk A/S Device for titrating basal insulin
WO2020251983A1 (fr) 2019-06-10 2020-12-17 Respira Therapeutics, Inc. Formulations à base de supports et procédés associés
US11007185B2 (en) 2019-08-01 2021-05-18 Incarda Therapeutics, Inc. Antiarrhythmic formulation
JP2023520049A (ja) 2020-03-31 2023-05-15 プロトマー・テクノロジーズ・インコーポレイテッド 隣接ジオールに対する選択的応答性のためのコンジュゲート
KR20230009499A (ko) * 2020-05-15 2023-01-17 일라이 릴리 앤드 캄파니 연장된 시간 작용 아실화된 인슐린 화합물
MX2023005935A (es) 2020-11-19 2023-05-29 Protomer Tech Inc Compuestos aromaticos que contienen boro y analogos de insulina.
WO2023225534A1 (fr) 2022-05-18 2023-11-23 Protomer Technologies Inc. Composés contenant du bore aromatiques et analogues d'insuline associés

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1902865A1 (de) * 1968-02-01 1969-09-11 American Home Prod Substituierte Insulin-Derivate,Verfahren zu ihrer Herstellung und ihre Verwendung in pharmazeutischen Zubereitungen
US3823125A (en) * 1969-10-14 1974-07-09 American Home Prod N-aminoacyl-substituted insulins
US3950517A (en) * 1970-05-08 1976-04-13 National Research Development Corporation Insulin derivatives
US3869437A (en) * 1970-05-08 1975-03-04 Nat Res Dev Mono-, di, and N{HD A1{B , N{HU B1{B , N{HU B29{B -tri-acylated insulin
GB1381274A (en) * 1971-01-28 1975-01-22 Nat Res Dev Insulin derivatives
GB1381273A (en) * 1971-01-28 1975-01-22 Nat Res Dev Insulin derivatives
US3864325A (en) * 1971-11-18 1975-02-04 Nat Res Dev (N{HU Al{b , N{HU Bl{b , N{HU B29{B , carbamoyl)-(O{HU A14{B , O{HU B16{B , O{HU B26{B aryl) insulin derivatives
BE791949A (fr) * 1971-11-27 1973-05-28 Schering Ag Derives d'insuline, leur preparation et leur utilisation
US3896437A (en) * 1973-10-11 1975-07-22 Sperry Rand Corp Apparatus for generating precise crossover frequency of two independent equal bandwidth spectra
GB1492997A (en) * 1976-07-21 1977-11-23 Nat Res Dev Insulin derivatives
DK347086D0 (da) * 1986-07-21 1986-07-21 Novo Industri As Novel peptides
PH25772A (en) * 1985-08-30 1991-10-18 Novo Industri As Insulin analogues, process for their preparation
JPH01254699A (ja) * 1988-04-05 1989-10-11 Kodama Kk インスリン誘導体及びその用途
PT93057B (pt) * 1989-02-09 1995-12-29 Lilly Co Eli Processo para a preparacao de analogos da insulina
WO1992001476A1 (fr) * 1990-07-26 1992-02-06 University Of Iowa Research Foundation Nouveaux systemes de liberation de medicaments pour proteines et peptides utilisant de l'albumine comme molecule porteuse
JP3014764B2 (ja) * 1993-09-17 2000-02-28 ノボ ノルディスク アクティーゼルスカブ アシル化インスリン
US5474978A (en) * 1994-06-16 1995-12-12 Eli Lilly And Company Insulin analog formulations
DE4437604A1 (de) * 1994-10-21 1996-04-25 Basf Ag Konjugate aus einem Poly- oder Oligopeptid und einer niedermolekularen lipophilen Verbindung
US5693609A (en) * 1994-11-17 1997-12-02 Eli Lilly And Company Acylated insulin analogs
DE69629210T2 (de) * 1995-03-17 2004-04-22 Novo Nordisk A/S Insulinabkömmlinge

Also Published As

Publication number Publication date
TR199501420A2 (tr) 1996-06-21
DE69530353D1 (de) 2003-05-22
MX9703508A (es) 1997-07-31
ES2194890T3 (es) 2003-12-01
EP0712861A3 (fr) 1998-03-11
CZ145797A3 (en) 1997-12-17
PL320644A1 (en) 1997-10-13
FI972031A (fi) 1997-05-14
AU4237396A (en) 1996-06-17
FI972031A0 (fi) 1997-05-13
EP0712861B1 (fr) 2003-04-16
HUT77030A (hu) 1998-03-02
ZA959679B (en) 1997-05-14
NZ297257A (en) 1999-05-28
US5693609A (en) 1997-12-02
DE69530353T2 (de) 2004-02-19
AR002700A1 (es) 1998-04-29
US5922675A (en) 1999-07-13
BR9509653A (pt) 1997-09-16
JPH10511644A (ja) 1998-11-10
WO1996015804A1 (fr) 1996-05-30
NO972169D0 (no) 1997-05-12
IL115973A0 (en) 1996-01-31
YU71395A (sh) 1998-07-10
TW434259B (en) 2001-05-16
KR970706842A (ko) 1997-12-01
ATE237635T1 (de) 2003-05-15
CO4520284A1 (es) 1997-10-15
EP0712861A2 (fr) 1996-05-22
AU711282B2 (en) 1999-10-07
RU2160118C2 (ru) 2000-12-10
NO972169L (no) 1997-05-12
CA2205060A1 (fr) 1996-05-30

Similar Documents

Publication Publication Date Title
IL115973A (en) Acylated insulin analogs and pharmaceutical compositions containing them
IL114622A0 (en) Heteroaryl-oxazolidinones and pharmaceutical compositions containing them
IL105218A0 (en) Hexanones and pharmaceutical compositions containing them
IL105223A0 (en) Cyclohexane-ylidenes and pharmaceutical compositions containing them
IL105220A0 (en) Cyclohexanylidene compounds and pharmaceutical compositions containing them
IL95351A0 (en) 17beta-acyl-4-aza-5alpha-androst-1-en-3-ones and pharmaceutical compositions containing them
IL111221A0 (en) N-alkyl-n- arylpyrimidinamine derivatives and pharmaceutical compositions containing them
IL116512A0 (en) Cyclic peptides their preparation and pharmaceutical compositions containing them
IL90067A0 (en) 1alpha-hydroxyvitamin-d compounds and pharmaceutical compositions containing them
IL110376A0 (en) Pharmaceutical compositions containing ifetroban and methods for the preparation thereof
IL122717A0 (en) Compounds and pharmaceutical compositions containing them
IL106098A0 (en) Heteroarylnaphthalenes and pharmaceutical compositions containing them
IL105222A0 (en) Cyclohex-1-ene compounds and pharmaceutical compositions containing them
IL128058A0 (en) Illudin analogs and pharmaceutical compositions containing the same
IL113329A (en) Pharmaceutical compositions containing n-substituted benzamides
IL97122A0 (en) Aromatase-inhibiting androstendiones and pharmaceutical compositions containing them
EP0587047A3 (en) Gestagenes containing pharmaceutical composition
IL116190A (en) Eleutherobin, analogs thereof and pharmaceutical compositions containing them
IL116101A0 (en) Benzamide its preparation and pharmaceutical compositions containing it
IL114623A0 (en) Substituted triazolylmethylphenylnaph-thyridones their preparation and pharmaceutical compositions containing them
IL89155A0 (en) Ouabain-like compounds and pharmaceutical compositions containing them
IL115982A (en) Cyclolignan derivatives and pharmaceutical compositions containing them
ZA944769B (en) Thf-gamma2 analogs and pharmaceutical compositions comprising them
IL113415A (en) Dihydrodibenziso-quinolinediones their preparation and pharmaceutical compositions containing them
IL114161A0 (en) Amido- quinoxalinediones pharmaceutical compositions containing them and their use

Legal Events

Date Code Title Description
KB Patent renewed